|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:K._Nityananda_Reddy
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:exportedTo
|
gptkb:Africa
gptkb:Asia
gptkb:Australia
gptkb:Europe
gptkb:United_States
|
|
gptkbp:foundedIn
|
1986
|
|
gptkbp:founder
|
gptkb:K._Nityananda_Reddy
gptkb:P._V._Ramprasad_Reddy
|
|
gptkbp:headquartersLocation
|
gptkb:Hyderabad
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Aurobindo Pharma
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:ISIN
|
INE406A01037
|
|
gptkbp:keyPerson
|
gptkb:K._Nityananda_Reddy
gptkb:K._Satyanarayana_Murthy
gptkb:P._V._Ramprasad_Reddy
|
|
gptkbp:listedOn
|
BSE: 524804
NSE: AUROPHARMA
|
|
gptkbp:location
|
gptkb:Hyderabad,_Telangana,_India
|
|
gptkbp:manufacturingFacilities
|
gptkb:Europe
gptkb:India
gptkb:USA
|
|
gptkbp:market
|
Global
|
|
gptkbp:numberOfEmployees
|
~23,000
|
|
gptkbp:parentCompany
|
gptkb:Aurobindo_Pharma_Limited
|
|
gptkbp:products
|
Active pharmaceutical ingredients
Generic pharmaceuticals
|
|
gptkbp:publiclyTraded
|
Yes
|
|
gptkbp:revenue
|
INR 24,774 crore (FY 2022-23)
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:stockSymbol
|
gptkb:AUROPHARMA
|
|
gptkbp:subsidiary
|
gptkb:Aurobindo_Pharma_USA
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.aurobindo.com/
|
|
gptkbp:bfsParent
|
gptkb:NOVN
|
|
gptkbp:bfsLayer
|
5
|